Clinical Trial Update: Safely Quenching Complement in Stroke Survivors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update from Columbia University investigating safely quenching complement in stroke survivors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Snippet

Sponsor: Columbia University | Conditions: Acute Ischemic Stroke, Cerebral Infarction | Phase 1 | Status: NOT_YET_RECRUITING